Inventor · disambiguated record
Wenyuan Qian
Also filed as: QIAN WENYUAN
41 granted patents·16 pending applications·159 citations·filing 2004–2023
96Inventor score
Files withAMGEN INC21MEDSHINE DISCOVERY INC8WUXI BIOCITY BIOPHARMACEUTICS CO LTD5CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD3KPC PHARMACEUTICALS INC2
Top patents by PatentIndex Score
57 records- 0196US9611261B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Apr 4, 2017·25 cites·40 claims
- 0295US9085576B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Jul 21, 2015·31 cites·60 claims
- 0394US8426447B2Spiro-tricyclic ring compounds as beta-secretase modulators and methods of useWHITE RYAN·Filed 2009·Granted Apr 23, 2013·58 cites·22 claims
- 0489US7538114B2Glycine transporter-1 inhibitorsAMGEN INC·Filed 2007·Granted May 26, 2009·14 cites·43 claims
- 0582US9303028B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2014·Granted Apr 5, 2016·4 cites·18 claims
- 0681US11434232B2ATR inhibitor and application thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2019·Granted Sep 6, 2022·2 cites·19 claims
- 0780US11919896B2[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Mar 5, 2024·2 cites·19 claims
- 0880US11613545B2Macrocyclic compound serving as Wee1 inhibitor and applications thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2018·Granted Mar 28, 2023·2 cites·20 claims
- 0980US8691986B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2013·Granted Apr 8, 2014·3 cites·8 claims
- 1078US9174992B2Heterobicyclic compoundsAMGEN INC·Filed 2013·Granted Nov 3, 2015·4 cites·17 claims
- 1176US8883782B2Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 1273US9296734B2Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Mar 29, 2016·2 cites·39 claims
- 1370US7662811B21,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of useAMGEN INC·Filed 2005·Granted Feb 16, 2010·1 cites·13 claims
- 1469US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 1567US7393852B2Piperazine derivatives and methods of useAMGEN INC·Filed 2004·Granted Jul 1, 2008·3 cites·42 claims
- 1666US8258306B2Glycine transporter-1 inhibitorsHITCHCOCK STEPHEN A·Filed 2008·Granted Sep 4, 2012·1 cites·11 claims
- 1765US8183244B2Glycine transporter-1 inhibitorsHITCHCOCK STEPHEN·Filed 2009·Granted May 22, 2012·0 cites·35 claims
- 1865US7425631B2Compounds and methods of useAMGEN INC·Filed 2004·Granted Sep 16, 2008·2 cites·6 claims
- 1962US9663476B2Glycine transporter-1 inhibitorsAMGEN INC·Filed 2014·Granted May 30, 2017·0 cites·20 claims
- 2060US12486266B2Crystalline form of JAK inhibitor and application thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2021·Granted Dec 2, 2025·0 cites·13 claims
- 2159US2025154108A1Crystal form of 7-azaspiro[4,5]decane-6,10-dione compound and preparation method thereforCMS RES & DEVELOPMENT PTE LTD·Filed 2023·Application pending·0 cites
- 2259US2025011332A1Pyrazolo fused ring compound and use thereofSOTER BIOPHARMA PTE LTD·Filed 2022·Application pending·0 cites
- 2359US2024376093A1Sulfoximine compound and use thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 2458US11345682B2Polymorph of HDAC6-selective inhibitor and application thereofCSTONE PHARMACEUTICALS SUZHOU CO LTD·Filed 2019·Granted May 31, 2022·0 cites·8 claims
- 2558US2024132482A1Benzo seven-membered ring bifunctional compound and application thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 2657US9493459B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2016·Granted Nov 15, 2016·0 cites·3 claims
- 2757US2009048224A1Compounds and methods of useAMGEN INC·Filed 2008·Application pending·0 cites
- 2857US2025188077A1Crystal form of 1h-pyrrolo[2,3-c]pyridine compound and preparation method thereforJUMBO DRUG BANK CO LTD·Filed 2023·Application pending·0 cites
- 2955US2023219960A11h-pyrazole derivative and application thereof as dual target inhibitor of syk and vegfr2OCUMENSION THERAPEUTICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 3054US2023128137A1Benzo five-membered cyclic compoundMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 3154US2009054460A1Piperazine derivatives and methods of useCHEN JIAN J·Filed 2008·Application pending·0 cites
- 3253US12428391B2Dimethylsulfoximine derivativeCISEN PHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 3352US12391653B2Salt form and crystal form of mutant IDH1 inhibitor and preparation method thereforKPC PHARMACEUTICALS INC·Filed 2020·Granted Aug 19, 2025·0 cites·20 claims
- 3452US12187710B2Salt of Syk inhibitor and crystalline form thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Jan 7, 2025·0 cites·17 claims
- 3552US2023017539A1Tri-heterocyclic compound as jak inhibitor, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 3650US11634424B2Diazaindole derivative and use thereof as CHK1 inhibitorMEDSHINE DISCOVERY INC·Filed 2020·Granted Apr 25, 2023·0 cites·13 claims
- 3749US12351590B2Pyrrolopyrimidine compound and use thereofGUANGZHOU JOYO PHARMATECH CO LTD·Filed 2020·Granted Jul 8, 2025·0 cites·17 claims
- 3848US12479839B2Crystalline form of ATR inhibitor and use thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2020·Granted Nov 25, 2025·0 cites·20 claims
- 3948US11384065B2Heterocyclic compound as CSF-1R inhibitor and use thereofMEDSHINE DISCOVERY INC·Filed 2019·Granted Jul 12, 2022·0 cites·19 claims
- 4048US11230544B1Substituted 1,3,4-thiadiazoles as GLS1 inhibitorsMEDSHINE DISCOVERY INC·Filed 2019·Granted Jan 25, 2022·0 cites·21 claims
- 4148US11230549B2Quinolino-pyrrolidin-2-one derivative and application thereofMEDSHINE DISCOVERY INC·Filed 2019·Granted Jan 25, 2022·0 cites·22 claims
- 4247US2015252011A1Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Application pending·0 cites
- 4347US2024132503A1Salt form and crystal form of pyrazole substituted imidazo[1,2- a]quinoxaline derivativeOCUMENSION THERAPEUTICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 4446US11299475B2Prostacyclin receptor agonistMEDSHINE DISCOVERY INC·Filed 2019·Granted Apr 12, 2022·0 cites·20 claims
- 4546US8735383B2Glycine transporter-1 inhibitorsSTEPHEN HITCHCOCK·Filed 2012·Granted May 27, 2014·0 cites·25 claims
- 4646US2017267673A1Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Application pending·0 cites
- 4745US12180184B2Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2019·Granted Dec 31, 2024·0 cites·22 claims
- 4845US11407717B2Benzimidazole derivatives and use thereof as IDH1 inhibitorsKPC PHARMACEUTICALS INC·Filed 2019·Granted Aug 9, 2022·0 cites·16 claims
- 4945US11021493B21,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jun 1, 2021·0 cites·33 claims
- 5045US2009227601A1Bradykinin 1 Receptor AntagonistsAMGEN INC·Filed 2006·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wenyuan Qian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →